Cytokinetics | CYTK - Debt



Cytokinetics reported $658.13M in Debt for its fiscal quarter ending in March of 2025.


Debt Change Date
Acadia Pharmaceuticals USD 56.29M 56.29M Jun/2025
Amgen USD 56.2B 1.18B Jun/2025
Bayer EUR 39.39B 1.31B Mar/2025
Biogen USD 6.59B 296.8M Jun/2025
Bristol-Myers Squibb USD 50.93B 1.22B Jun/2025
Cytokinetics USD 658.13M 1.01M Mar/2025
Eisai JPY 187.52B 31.58B Mar/2025
Eli Lilly USD 39.9B 1.39B Jun/2025
Exelixis USD 179.84M 179.84M Jun/2025
Geron USD 121.84M 3.12M Jun/2025
Halozyme Therapeutics USD 1.51B 1.65M Jun/2025
Ionis Pharmaceuticals USD 1.42B 169.27M Jun/2025
Ligand Pharmaceuticals USD 24K 0 Mar/2025
Merck USD 34.84B 2.27B Mar/2025
Novartis USD 31.27B 12M Mar/2025
Pfizer USD 60.93B 1.18B Jun/2025
Regeneron Pharmaceuticals USD 2.71B 300K Jun/2025
Roche Holding CHF 34.44B 5.23B Jun/2024
Sanofi 22.28B 1.24B Jun/2025